» Go to news main
Molly Appeal paves the way to precision cancer treatment
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
- Part of the plan: On‑campus rapid testing provides extra layer of protection at Dal
- Global Health Office holds virtual year‑end celebration to commemorate its community partners
- Alumni achievements: Meet Dalhousie’s 2021 Aurum Award winners
- Students build knowledge‑mobilization skills in partnership with national children’s pain management network
- Grad Profiles ‑ Class of 2021 ready for what comes next: Perseverance on the path to graduation
- “All hands on deck” hits a whole new level: Learners and staff pitch in to process COVID backlog, stay ahead of third wave
- Dal Study Shows Importance of Physical activity and Social Connection for Kids during COVID‑19 Lockdowns
- Dal prof receives Governor General’s Innovation Award for 3D printed devices that improve cancer treatment